Arne Bartol

1.5k total citations
10 papers, 771 citations indexed

About

Arne Bartol is a scholar working on Molecular Biology, Economics and Econometrics and Oncology. According to data from OpenAlex, Arne Bartol has authored 10 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Economics and Econometrics and 3 papers in Oncology. Recurrent topics in Arne Bartol's work include Angiogenesis and VEGF in Cancer (4 papers), Economic and Financial Impacts of Cancer (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Arne Bartol is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Economic and Financial Impacts of Cancer (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Arne Bartol collaborates with scholars based in Germany and Switzerland. Arne Bartol's co-authors include Hellmut G. Augustin, Thomas Korff, Abdullah Alajati, Holger Weber, Anna Laib, Andreas Fischer, Sven S. Liebler, Rupesh K. Srivastava, Nicolas Gengenbacher and Junhao Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Circulation Research.

In The Last Decade

Arne Bartol

10 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arne Bartol Germany	7	380	141	134	116	115	10	771
Benjamin Himes United States	15	411 1.1×	138 1.0×	118 0.9×	188 1.6×	62 0.5×	36	932
И. В. Холоденко Russia	18	467 1.2×	209 1.5×	78 0.6×	226 1.9×	137 1.2×	51	945
Lucia Salvatorelli Italy	24	533 1.4×	102 0.7×	139 1.0×	175 1.5×	161 1.4×	73	1.3k
Demetrios C. Nikas United States	9	290 0.8×	86 0.6×	63 0.5×	138 1.2×	60 0.5×	16	817
Jonathan Serrano United States	15	369 1.0×	169 1.2×	120 0.9×	146 1.3×	97 0.8×	35	907
Catherine Sweeney Ireland	11	493 1.3×	107 0.8×	38 0.3×	63 0.5×	94 0.8×	11	819
Hema Vasavada United States	11	480 1.3×	35 0.2×	86 0.6×	83 0.7×	110 1.0×	16	901
Piotr Rieske Poland	21	680 1.8×	127 0.9×	88 0.7×	312 2.7×	120 1.0×	88	1.3k
Sara Nava Italy	18	282 0.7×	130 0.9×	77 0.6×	342 2.9×	66 0.6×	29	894
Lorenzo Veschini Italy	13	288 0.8×	67 0.5×	115 0.9×	92 0.8×	89 0.8×	20	681

Countries citing papers authored by Arne Bartol

Since Specialization

Citations

This map shows the geographic impact of Arne Bartol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Bartol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Bartol more than expected).

Fields of papers citing papers by Arne Bartol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Bartol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Bartol. The network helps show where Arne Bartol may publish in the future.

Co-authorship network of co-authors of Arne Bartol

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Bartol. A scholar is included among the top collaborators of Arne Bartol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Bartol. Arne Bartol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Wasem, Jürgen, et al.. (2023). Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit. Health Economics Policy and Law. 19(2). 216–233. 1 indexed citations

2.

Bartol, Arne, et al.. (2022). Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion. Journal of Cancer Research and Clinical Oncology. 149(6). 2637–2645. 3 indexed citations

3.

Bartol, Arne, et al.. (2022). Zehn Jahre AMNOG-Prozess aus Sicht der Onkologie. Forum. 37(1). 84–90. 1 indexed citations

4.

Mahlich, Jörg, et al.. (2021). Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis. Health Economics Review. 11(1). 4–4. 11 indexed citations

5.

Teichert, Martin, Laura Milde, Annegret Holm, et al.. (2017). Pericyte-expressed Tie2 controls angiogenesis and vessel maturation. Nature Communications. 8(1). 16106–16106. 247 indexed citations

6.

Bieback, Karen, Maria Vinci, Arne Bartol, et al.. (2013). Recruitment of human cord blood-derived endothelial colony-forming cells to sites of tumor angiogenesis. Cytotherapy. 15(6). 726–739. 23 indexed citations

7.

Liebler, Sven S., Arne Bartol, Mohamed Adam, et al.. (2010). Integrin Cytoplasmic Domain–Associated Protein-1 Attenuates Sprouting Angiogenesis. Circulation Research. 107(5). 592–601. 55 indexed citations

8.

Bartol, Arne, Sven S. Liebler, Yuan Zhu, et al.. (2010). Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proceedings of the National Academy of Sciences. 107(28). 12640–12645. 151 indexed citations

9.

Laib, Anna, Arne Bartol, Abdullah Alajati, et al.. (2009). Spheroid-based human endothelial cell microvessel formation in vivo. Nature Protocols. 4(8). 1202–1215. 114 indexed citations

10.

Alajati, Abdullah, Anna Laib, Holger Weber, et al.. (2008). Spheroid-based engineering of a human vasculature in mice. Nature Methods. 5(5). 439–445. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact